MENU
+Compare
CNS
Stock ticker: NYSE
AS OF
Apr 25 closing price
Price
$76.20
Change
-$0.65 (-0.85%)
Capitalization
3.7B

CNS Cohen & Steers Forecast, Technical & Fundamental Analysis

Cohen & Steers is a niche asset manager concentrating on real estate securities... Show more

CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CNS with price predictions
Apr 25, 2025

CNS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CNS turned positive on April 22, 2025. Looking at past instances where CNS's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CNS's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where CNS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 25, 2025. You may want to consider a long position or call options on CNS as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNS advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

CNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CNS entered a downward trend on April 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.709) is normal, around the industry mean (2.779). P/E Ratio (28.735) is within average values for comparable stocks, (27.202). Projected Growth (PEG Ratio) (4.903) is also within normal values, averaging (3.172). Dividend Yield (0.031) settles around the average of (0.071) among similar stocks. P/S Ratio (7.559) is also within normal values, averaging (11.704).

View a ticker or compare two or three
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CNS is expected to report earnings to fall 2.67% to 73 cents per share on July 16

Cohen & Steers CNS Stock Earnings Reports
Q2'25
Est.
$0.73
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.01
The last earnings report on April 16 showed earnings per share of 75 cents, beating the estimate of 74 cents. With 99.60K shares outstanding, the current market capitalization sits at 3.70B.
A.I.Advisor
published Dividends

CNS paid dividends on March 13, 2025

Cohen & Steers CNS Stock Dividends
А dividend of $0.62 per share was paid with a record date of March 13, 2025, and an ex-dividend date of March 03, 2025. Read more...
A.I. Advisor
published General Information

General Information

a company which specializes in assets and capital management and investment services

Industry InvestmentManagers

Profile
Fundamentals
Details
Industry
Investment Managers
Address
1166 Avenue of the Americas
Phone
+1 212 832-3232
Employees
405
Web
https://www.cohenandsteers.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WVCCX30.780.21
+0.69%
abrdn International Small Cp A
OSVCX15.05N/A
N/A
JPMorgan Small Cap Value C
ANOYX20.80N/A
N/A
American Century Small Cap Growth Y
HERFX10.08N/A
N/A
Hartford Emerging Markets Equity F
NZDCHF0.50N/A
N/A
New Zealand Dollar - Switzerland Franc

CNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNS has been closely correlated with APAM. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNS jumps, then APAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNS
1D Price
Change %
CNS100%
-0.85%
APAM - CNS
70%
Closely correlated
-0.32%
APO - CNS
64%
Loosely correlated
+0.06%
VRTS - CNS
61%
Loosely correlated
-2.27%
TROW - CNS
61%
Loosely correlated
-1.21%
BX - CNS
60%
Loosely correlated
-1.26%
More

Groups containing CNS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNS
1D Price
Change %
CNS100%
-0.85%
CNS
(4 stocks)
82%
Closely correlated
-1.17%